Tuberculosis (TB) is the most common opportunistic infection in Human Immunodeficiency Virus 1 (HIV-1) infected individuals. TB/HIV co-infection makes diagnosis, treatment and presentation of TB a challenge resulting in high mortality from TB in HIV-infected population. In 2012, the Ministry of Health of Mozambique strategically adopted a one-stop model of care, aiming to increase TB screening and treatment for HIV infected patients. Here we evaluate the effect of this strategy on access and retention to TB and HIV services at health facility (HF) level in Maputo province.
HF offering HIV and TB care services before 2012 and after 2013 are included. Indicators per HF were computed from an electronic patient track system (ePTS). Interrupted time series (ITS) analysis of HF level indicators was conducted. Time segments included before July 2012 (PRE:segment 1), the 12 months between PRE and POST (segment 3) and after June 2013 (POST: Segment 3) and Generalized estimating equation (GEE) linear and logistic regressions with robust standard errors were used to estimate per indicator the change on the level and the slope from PRE to POST.
In total 24 HF were included in the analysis (N=3; Urban and N=21; Rural). Of these, one provided secondary level of care. The odds of TB screening increased significantly from end of segment 1 to beginning of segment 3 (OR: 4.10; 95%CI 2.41 – 6.99) and from a monthly odds-ratio of 1.06 to 1.12 respectively. Conversely, the mean time to ART initiation decreased from 180 days at the end of period 1 to 108 days at beginning of period 3 (relative decrease: 40%; 95%CI 32-47%) (Figure 1) and from monthly mean decrease of 2% to 5%. By July 2015, the mean time to ART initiation was less than 1 month. The odds to access to cothrimoxazole prophylaxis within 3 months of registration increased from end of period 1 to end of period 3 (OR: 2.21; 95% CI 1.75 – 2.81). Overall, no significant changes were observed in retention at 12 months, however it has improved from 77% to 88% among adolescents
Our results suggest benefit of this model of care for co-infected patients. Of note is the reduced time to ART initiation to less than 30 days coupled to improved access to cothrimoxazole prophylaxis. These two factors together with improved screening may significantly contribute to a reduction in mortality and morbidity associated to TB/HIV co-infection.